Fingerprint
Dive into the research topics of 'Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant for the acute treatment of migraine attacks'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant for the acute treatment of migraine attacks
Olivia Begasse de Dhaem, Tsubasa Takizawa, David W. Dodick
Research output: Contribution to journal › Review article › peer-review
3
Citations
(Scopus)